Table 1 Subjects baseline characteristics
Variable | Total | Control group | ACD Cases group | p-value | ||
|---|---|---|---|---|---|---|
(n = 62) | (n = 31) | (n = 31) | Before Treatment | After Treatment | ||
Male | 32 (52%) | 16 (52%) | 16 (52%) | 1.000† | ||
Female | 30 (48%) | 15 (48%) | 15 (48%) | |||
Age (y) | 40 ± 17 | 43 ± 16 | 38 ± 19 | 0.454** | ||
QRS scoring | 1.2 ± 1.9 | 0,06 ± 0.36 | 1.1 ± 1.5‡‡ | 2.6 ± 2.2‡‡ | < 0.001‡ | |
Predicted LV infarct (%) | 3.7 ± 5.5 | 0.2 ± 1.1 | 3.3 ± 4.5‡‡ | 7.7 ± 6.6‡‡ | < 0.001‡ | |
LVEF (%) | 73 ± 6.3 | 75 ± 4.6 | 73 ± 7.3 | 0.092‡ | ||
NYHA I | 61 (98.4%) | 31 (100%) | 30 (97%) | 31 (100%) | ||
NYHA III | 1 (1.6%) | 1 (3%) | ||||